We examined the resistance phenotype and the genetic basis of lincosamide modification in 25 clinical isolates of Staphylococcus spp. inactivating lincomycin and clindamycin. The strains were resistant to high levels of lincomycin but remained susceptible to clindamycin. However, MBCs and inoculum effects showed that the activity of clindamycin was impaired. The distribution in these strains of nucleotide sequences related to linA and linA', the genes encoding lincosamide nucleotidylation in Staphylococcus haemolyticus BM4610 and S. aureus BM4611, respectively, was studied by dot blot hybridization. The genes responsible for lincosamide inactivation in Staphylococcus spp. were found to constitute a family of related sequences which are not species specific.
The lincosamide antibiotics lincomycin and clindamycin are useful in the treatment of infections due to anaerobes and gram-positive cocci (6) . Resistance of staphylococci to these drugs usually involves alteration of the ribosome following N6-dimethylation of an adenine residue in 23S rRNA (23) . This resistance is associated with coresistance to macrolide and streptogramin B-type antibiotics, the so-called MLS phenotype (3, 4) . Another type of resistance toward lincomycin has been reported that occurs in staphylococci of animal origin which resist by inactivating the antibiotic (5). We recently described a human clinical isolate, Staphylococcus haemolyticus BM4610, which is highly resistant to lincomycin (MIC, 64 p,g/ml) and inactivates lincomycin and clindamycin (12) . Lincosamide inactivation in this strain is due to synthesis of a 4-lincosamide O-nucleotidyltransferase, which catalyzes the nucleotidylation of the hydroxyl group in position 4 of lincomycin and clindamycin (A. Brisson-Noel, P. Delrieu, D. Samain, and P. Courvalin, manuscript in preparation). The nucleotide sequence of the plasmid gene linA responsible for this new phenotype in BM4610 has been determined (1) . A 77-base-pair fragment internal to this gene was used as a probe in hybridization experiments to study the dissemination of linA in staphylococci resisting lincomycin by inactivation. S. aureus BM4611 did not hybridize to the probe and was studied further. Gene linA', which encodes a 4-lincosamide 0-nucleotidyltransferase in this strain, was sequenced and compared with linA (Brisson-Noel et al., in preparation).
Both genes are 483 base pairs long but differ by 34 base substitutions, and the derived proteins differ by 14 amino acids. In this paper we study the phenotypic expression of resistance to lincosamides by inactivation and the distribution of linA, linA', and related genes in clinical isolates of staphylococci. (10) . S. aureus strains were isolated from abcesses, and coagulase-negative staphylococci were isolated from wound infections, intravenous catheters, and urine samples. The incidence of lincomycin resistance was 0.2% in S. aureus (2,100 strains screened), 4 .6% in S. epidermidis (240 strains screened), and 8% in S. cohnii (50 strains screened). S. haemolyticus BM4610 harboring linA (1, 12) , its cured derivative BM4610-1 (12), S. aureus BM4611 harboring linA' (Brisson-Noel et al., in preparation), and antibiotic-susceptible S. aureus RN450 (17) and 209P were included as controls.
MATERIALS AND METHODS
Media. Brain heart infusion broth and agar (Difco Laboratories, Detroit, Mich.) were used as media. Antibiotic susceptibility tests were performed with Mueller-Hinton broth and agar (Diagnostics Pasteur, Marnes-la-Coquette, France). All incubations were done at 37°C.
Determination of MICs and MBCs. The method of Steers et al. (19) was used to determine the MICs of the antibiotics in solid medium. The MICs and MBCs (.99.9% reduction in CFU per milliliter) of clindamycin were also determined by macrodilution in liquid medium (21) with an inoculum of approximately 5 x 105 CFU/ml. To study the effect of the size of the inoculum, clindamycin MICs in liquid medium were determined with the standard inoculum (5 x 105 CFU/ml) and with a 102-fold-higher inoculum (5 x 107 CFU/ml).
Inactivation of MLS antibiotics. Inactivation of MLS antibiotics was screened by the test described by Gots (7) and modified as follows. The test strains were streaked on the surfaces of plates containing Micrococcus luteus ATCC 9341 as the indicator organism and concentrations of MLS antibiotics slightly higher than the MICs of these antibiotics for M. luteus. Inactivation of the antibiotic in the culture medium by the test organism allowed growth of the indicator organism in the surrounding medium.
Preparation of DNA. Cells from 1.5 ml of an overnight broth culture were harvested, suspended in 100 ,ul of 0. (15) replicative-form DNA and transfected in Escherichia coli JM101 (14) , and single-stranded recombinants were purified and labeled (9) (Table 2) medium. However, the bactericidal activity of clindamycin was impaired, since its MBCs were 4-to 32-fold higher than that against the susceptible strains BM4610-1 and 209P (Table 2) . When determined with a 102-fold-higher inoculum in liquid medium, the MICs of clindamycin were approximately 10 times higher against the resistant strains than against the susceptible reference strains ( Table 2) .
Construction of intragenic probes. The sequences of genes linA (1) and linA' (Brisson-Noel et al., in preparation) have been determined. Comparison of the sequences obtained allowed the construction of three probes (Fig. 1) . A 77-basepair Sau3A DNA fragment of linA (linA probe) was intended to be specific for linA, whereas two fragments generated by BAL 31 exonuclease and intragenic to linA' were supposed to hybridize to linA' only (linA' probe) or to linA, linA', and related genes (linA-like probe), respectively. The specificity of these DNA fragments towards the two genes was predicted by calculating the melting temperature of homo-or heteroduplex DNA with the theoretical formula (2, 13) Fig. 2; Table 4 ). Homology with the linA-like probe designed to hybridize to linA, linA', and related sequences was detected in all the strains studied. Of these strains, 15 hybridized with the linA probe, 7 hybridized with the linA' probe, and 3 S. cohnii strains did not share homology with either probe. It seems, therefore, that other classes of genes specifying lincosamide detoxification that are similar but not identical to linA and linA' exist in nature. The lin genes, which appear to form a sequence continuum, obviously derive from a common ancestor. The classes are not species specific, since linA and linA' were present in S. aureus and S. epidermidis, but no strain was found to harbor both genes (Table 4) . Differences in levels of lincomycin resistance (Table 1) did not correlate with hybridization classes (Table  4 ). The hybridization results confirmed that the probes were adequately designed. As expected, linA and linA' probes were highly specific, whereas the linA-like probe not only hybridized with all the strains harboring linA or linA' but also allowed the detection of other sequences related to these genes. The theoretical approach used, which requires comparative sequence data, allows the construction of probes with different and predictable specificities.
DNA probes have proved useful in the study of the distribution of certain resistance genes and in the detection of new resistance determinants (20 These observations emphasize the need for two types of probes depending upon the goal of the study. Detection of resistance has to take into account the existence of gene classes and of gene variants within a given class. Thus, a universal probe would consist of a mixture of fragments specific for each class and as long as possible to overcome intraclass variability. In contrast, short probes, natural or synthetic, can be used to discriminate gene variants.
There are two pitfalls in the detection of lincosamide resistance of staphylococci. First, the strains appear susceptible to clindamycin. This might lead to erroneous therapy, since the drug is inactivated and has impaired bactericidal activity, a possibility which is being tested in animal models. Lincomycin as well as clindamycin should therefore be used in routine tests. Second, genes encoding this type of resistance display an unusual sequence variability, which has to our knowledge not yet been described for other resistance gene systems.
